Cargando…
Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectrosco...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658973/ https://www.ncbi.nlm.nih.gov/pubmed/37981674 http://dx.doi.org/10.1186/s13065-023-01077-z |
_version_ | 1785148267943690240 |
---|---|
author | Ghasemi, Nastaran Moradi, Shahram Iraji, Aida Mahdavi, Mohammad |
author_facet | Ghasemi, Nastaran Moradi, Shahram Iraji, Aida Mahdavi, Mohammad |
author_sort | Ghasemi, Nastaran |
collection | PubMed |
description | Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectroscopy techniques, including FTIR, Mass, (1)H-NMR, and (13)C-NMR. Next, the inhibitory activities of all derivatives were examined against tyrosinase, and, 6a as the most potent compound, exhibited an IC(50) value of 28.50 µM. Furthermore, the kinetic study of 6a was performed to better understand the inhibitory mechanism and its type of inhibition. The UV/Vis spectra analysis was also executed to provide valuable evidence supporting the inhibitory mechanism of compound 6a in the context of tyrosinase inhibition. Also, molecular docking and dynamic molecular study of 6a were executed to study its interactions within the enzyme’s binding site. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-01077-z. |
format | Online Article Text |
id | pubmed-10658973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106589732023-11-19 Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor Ghasemi, Nastaran Moradi, Shahram Iraji, Aida Mahdavi, Mohammad BMC Chem Research Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectroscopy techniques, including FTIR, Mass, (1)H-NMR, and (13)C-NMR. Next, the inhibitory activities of all derivatives were examined against tyrosinase, and, 6a as the most potent compound, exhibited an IC(50) value of 28.50 µM. Furthermore, the kinetic study of 6a was performed to better understand the inhibitory mechanism and its type of inhibition. The UV/Vis spectra analysis was also executed to provide valuable evidence supporting the inhibitory mechanism of compound 6a in the context of tyrosinase inhibition. Also, molecular docking and dynamic molecular study of 6a were executed to study its interactions within the enzyme’s binding site. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-01077-z. Springer International Publishing 2023-11-19 /pmc/articles/PMC10658973/ /pubmed/37981674 http://dx.doi.org/10.1186/s13065-023-01077-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ghasemi, Nastaran Moradi, Shahram Iraji, Aida Mahdavi, Mohammad Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
title | Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
title_full | Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
title_fullStr | Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
title_full_unstemmed | Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
title_short | Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
title_sort | thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658973/ https://www.ncbi.nlm.nih.gov/pubmed/37981674 http://dx.doi.org/10.1186/s13065-023-01077-z |
work_keys_str_mv | AT ghaseminastaran thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor AT moradishahram thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor AT irajiaida thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor AT mahdavimohammad thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor |